Priveq closes most successful exit ever in Swedish Orphan International

By 14/01/2010No Comments

Priveq investment has as of today closed the exit transaction made on November 5th, 2009, thus sealing the outcome of the most successful exit, money multiple-wise, of our 27 years of history. The transaction was conditioned by a positive outcome in the Biovitrum EGM as of December 4th 2009.
Thereby concluding a >26x-investment, excluding a possible additional 3x dependant on further company performance, with an IRR exceeding 80 per cent we are happy to contribute to the initiation of a new, strong, Swedish specialist pharmaceutical company in the listed Swedish Orphan Biovitrum AB.
For more information, please contact us at +46 8 459 67 60.

[hr top=”20″ bottom=”20″]
[register_getpdf pdftitle=”Press release” pdflink=””]
[hr top=”20″ bottom=”20″]